Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
2836161
Reference Type
Journal Article
Title
Positive-charged solid lipid nanoparticles as paclitaxel drug delivery system in glioblastoma treatment
Author(s)
Chirio, D; Gallarate, M; Peira, E; Battaglia, L; Muntoni, E; Riganti, C; Biasibetti, E; Capucchio, MT; Valazza, A; Panciani, P; Lanotte, M; Annovazzi, L; Caldera, V; Mellai, M; Filice, G; Corona, S; Schiffer, D
Year
2014
Is Peer Reviewed?
1
Journal
European Journal of Pharmaceutics and Biopharmaceutics
ISSN:
0939-6411
EISSN:
1873-3441
Volume
88
Issue
3
Page Numbers
746-758
Language
English
PMID
25445304
DOI
10.1016/j.ejpb.2014.10.017
Web of Science Id
WOS:000346951200019
Abstract
Paclitaxel loaded solid lipid nanoparticles (SLN) of behenic acid were prepared with the coacervation technique. Generally, spherical shaped SLN with mean diameters in the range 300–600 nm were obtained. The introduction of charged molecules, such as stearylamine and glycol chitosan into the formulation allowed to obtain positive SLN with Zeta potential in the 8-20 mV range and encapsulation efficiency in the 25–90% range.Blood–brain barrier (BBB) permeability, tested in vitro through hCMEC/D3 cells monolayer, showed a significantly increase in the permeation of Coumarin-6, used as model drug, when vehicled in SLN. Positive-charged SLN do not seem to enhance permeation although stearylamine-positive SLN resulted the best permeable formulation after 24 h.Cytotoxicity studies on NO3 glioblastoma cell line demonstrated the maintenance of cytotoxic activity of all paclitaxel-loaded SLN that was always unmodified or greater compared with free drug. No difference in cytotoxicity was noted between neutral and charged SLN.Co-culture experiments with hCMEC/D3 and different glioblastoma cells evidenced that, when delivered in SLN, paclitaxel increased its cytotoxicity towards glioblastoma cells.
Keywords
Paclitaxel; SLN; Coacervation; BBB permeability; Cytotoxicity; Glioblastoma
Tags
•
LitSearch-NOx (2024)
TIAB Screening
Atmospheric
Round 1
Exclude
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity